Department of Paediatric Surgery, National University Hospital, Singapore, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Transplant Proc. 2024 Sep;56(7):1585-1592. doi: 10.1016/j.transproceed.2024.08.019. Epub 2024 Aug 19.
To review the impact of the operating microscope (OM) for reconstruction of the hepatic artery (HA) by comparing the outcomes with standard loupe reconstruction (SL) in pediatric liver transplantation (LT).
Studies comparing the application of OM and SL for the reconstruction of the HA in primary pediatric LT were included from a systematic search of MEDLINE, Cochrane Library and EMBASE from inception to June 2022. Re-transplantation, dual grafts and auxiliary transplants were excluded. Primary outcome was the rate of HA thrombosis (HAT). Secondary outcomes were graft loss and mortality.
There were 1261 liver recipients from 9 included studies published until June 2022. There were 484 patients in the OM group and 777 patients in the SL group. HAT incidence with OM was significantly lower with OR = 0.18 (95% CI: 0.07-0.48). The 1-year graft survival was significantly better in the OM group with OR = 2.77 (95% CI: 1.13-6.80). 1-year overall mortality was also significantly lower with OM with OR = 0.39 (0.18-0.86). The use of OM did not significantly impact the incidence of HAT in the living donor liver transplant subgroup. Differences in time for hepatic HA reconstruction, total operating time and length of hospital stay did not reach statistical significance.
The use of OM has reduced the risk of HAT, graft loss and mortality in pediatric liver transplantation. Adoption of microsurgical principles in general may have contributed to the improved outcomes with SL reconstruction of HA in pediatric LT.
通过比较显微镜手术(OM)和标准手术放大镜(SL)重建肝动脉(HA)的结果,来评估 OM 在小儿肝移植(LT)中重建 HA 的效果。
从 MEDLINE、Cochrane 图书馆和 EMBASE 系统地搜索了从成立到 2022 年 6 月比较 OM 和 SL 应用于小儿 LT 中 HA 重建的研究。排除再次移植、双移植物和辅助移植。主要结局是 HA 血栓形成(HAT)的发生率。次要结局是移植物丢失和死亡率。
截至 2022 年 6 月,共纳入了 9 项研究中的 1261 例肝移植受者。OM 组有 484 例患者,SL 组有 777 例患者。OM 组的 HAT 发生率显著降低,OR = 0.18(95%CI:0.07-0.48)。OM 组 1 年移植物存活率显著提高,OR = 2.77(95%CI:1.13-6.80)。OM 组 1 年总死亡率也显著降低,OR = 0.39(0.18-0.86)。OM 对活体供肝移植亚组的 HAT 发生率没有显著影响。HA 重建时间、总手术时间和住院时间的差异没有达到统计学意义。
OM 的使用降低了小儿肝移植中 HAT、移植物丢失和死亡率的风险。在小儿 LT 中,HA 的 SL 重建采用显微外科原则可能是导致结局改善的原因之一。